Literature DB >> 11721398

[The clinical implications of IgG subclass in 84 patients with autoimmune hemolytic anemia].

Y Zhang1, Y Chu, Z Shao.   

Abstract

OBJECTIVE: To evaluate the clinical implications of IgG subclass in autoimmune hemolytic anemia(AIHA).
METHODS: Data of 84 AIHA patients were retrospectively analyzed.
RESULTS: In the 84 patients, IgG1 + IgG3 + C3d accounted for 45.0%, IgG1 + IgG3 15.5%, IgG1 + C3d 11.0%, C3d 10.7%, IgG1 9.5% and IgG3 + C3d 8.3%. IgG3 patients had the most severity of clinical and laboratory findings, followed by IgG1 patients. In IgG1 and IgG3 subgroups, the severity of hemolysis was positively correlated with the score of Coombs' test. The response rates of IgG3 and IgG1 patients were 68.2% and 100%, respectively.
CONCLUSION: In AIHA, the basic predominant IgG subclass is IgG1. IgG3 has a greater potential for red-cell destruction than IgG1 and C3d.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 11721398

Source DB:  PubMed          Journal:  Zhonghua Xue Ye Xue Za Zhi        ISSN: 0253-2727


  3 in total

1.  Clinical features and outcomes of autoimmune hemolytic anemia: a retrospective analysis of 32 cases.

Authors:  Seung-Woo Baek; Myung-Won Lee; Hae-Won Ryu; Kyu-Seop Lee; Ik-Chan Song; Hyo-Jin Lee; Hwan-Jung Yun; Samyong Kim; Deog-Yeon Jo
Journal:  Korean J Hematol       Date:  2011-06-21

2.  [Chinese expert consensus on the diagnosis and treatment of autoimmune hemolytic anemia (2017) Red Blood Cell Disease (Anemia)].

Authors: 
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2017-04-14

3.  Interference in the indirect antiglobulin test and direct antiglobulin test from rheumatoid factor.

Authors:  Lei Xu; Hao Li; Sishi Yang; Wenjuan Zeng; Shan Gan; Xin Chen; Ling Duan; Hongbing Hu
Journal:  J Int Med Res       Date:  2019-12-19       Impact factor: 1.671

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.